Command Palette

Search for a command to run...

Clinical Trials · NCT05503927

A Study to Evaluate the Safety of Exposure to Wegovy During Pregnancy

Enrolling By InvitationN/ASemaglutide (Investigational)
Phase
N/A
Recruitment status
Enrolling By Invitation
Sponsor
Novo Nordisk A/S
Enrollment
1,139
Start date
Feb 2020
Locations
2 sites, United States
Primary endpoint
Number of Infants with Major Congenital Malformation (MCM)
View Semaglutide compound reference